The vascular closure devices market report provides an overall understanding of market. In this report, market segmented on basis of type, access, procedures, and geographies. Type segment includes passive approximators, active approximators, & external hemostasis devices.
The geographic segments in vascular closure device market report include North America, Europe, Asia-Pacific, and RoW. Of these, the North American segment is expected to account for the largest share of the market in 2017. The large share of this segment can primarily be attributed to the high prevalence of cardiovascular diseases in the U.S., growing trend of one-day surgery for vascular procedures, and increasing research and clinical trials for vascular closure devices.
Complete report on Vascular Closure Device Market spread across 128 Pages, Profiling 13 Companies and Supported with 61 Tables and 30 Figures is now available at http://www.reportsnreports.com/reports/992564-vascular-closure-device-market-by-type-passive-approximators-collagen-plugs-sealent-gel-based-active-approximators-clip-suture-devices-access-femoralradial-procedure-interventional-cardiology-radiolo-ts-to-2022.html .
The global vascular closure devices market is expected to reach USD 984.6 Million by 2022 from USD 704.8 Million in 2017, at a CAGR of 6.9%. Vascular Closure Device market is segmented on the basis of type, access, procedure, and geography. The type segment includes passive approximat ors, active approximators, and external he most as is devices.
Target Audience for this Report:
- Vendors/service providers
- Research institutes
- Contract research organizations (CROs)
- Contract manufacturing organizations (CMOs)
- Interventional cardiology vascular device manufacturers
- Healthcare institutions (hospitals, medical schools, group practices, individual surgeons, and governing bodies)
- Niche companies manufacturing novel vascular closure devices
- Research and consulting firms
The vascular closure devices market report access segment includes femoral access and radial access. The procedure segment includes interventional cardiology and interventional radiology/vascular surgery. The geographic segments included in this report are North America, Europe, Asia-Pacific, and the Rest of the World (RoW).
Interested in this New Research Study the with Discount and More Information is Available Now
Major drivers for vascular closure devices market include large number of approvals for vascular closure devices, high prevalence of cardiovascular diseases, high prevalance of obesity, & increasing focus of market players on large-bore vascular closure devices. Passive approximators segment expected to account for largest share of vascular closure devices market in 2017. Passive approximators are most commonly used vascular closure devices in the market owing to their increased safety & fewer complications than manual procedures.
2 Vendor Dive Overview
5 Emerging Players
6 Dynamic Players
7 Competitive Benchmarking
8 Analysis of the Product Portfolio of Major Players in the Market (23 Companies)
9 Business Strategies Adopted By Major Players in the Market (23 Companies)
Major players include Terumo Corporation (Japan), Abbott (U.S.), Cardinal Health Inc. (U.S.), and Cardiva Medical Inc. (U.S.).Other players include Morris Innovative, Inc. (U.S.), Medtronic plc (Ireland), Essential Medical, Inc. (U.S.), Merit Medical Systems, Inc. (U.S.), TZ Medical, Inc. (U.S.), and Vasorum Ltd.(Ireland).
Click now for More Details, Other Information and Sample of this study “Vascular Closure Device Market by Type (Passive Approximators (Collagen Plugs Sealent/Gel Based), Active Approximators (Clip, Suture Devices)), Access (Femoral,Radial) & Procedure (Interventional Cardiology, Radiology) – Global Forecasts to 2022” report @ http://www.reportsnreports.com/contacts/discount.aspx?name=992564 .
Procedures segment of vascular closure devices market includes interventional cardiology and interventional radiology/vascular surgery. The interventional cardiology segment is expected to hold the largest share of the market in 2017. The large share of this segment can primarily be attributed to the high prevalence of cardiovascular diseases and increasing obese population across the globe.